5 / 14
Page 20
Notes:
allied
academies
Curr Trend Cardiol. 2017 | Volume 1 Issue 3
September 18-19, 2017 | Toronto, Canada
Annual Conference on
HEART DISEASES
Introduction:
There is not a consensus about the safety of
statin therapy in the elderly, let alone the oldest of the old.
Purpose:
This paper presents a case report of a 75 year old
lady who survived an acute myocardial infarction and has
been maintained on statin and aspirin therapy, along with
a calcium channel blocker for coronary vasodilatation (not
hypertension), with no other intervention. She is now 101
and ½ years old, still on medication and free of any clinical
complications.
Methods:
This is a case report of a single patient and her
outcome on optimal medical therapy. This case is unique
because it is the only case in the world, to the author’s
knowledge, of statin therapy in a patient in the eleventh
decade of life.
Results:
Thepatientinquestionsustainedanacutemyocardial
infarction at age 75 years. Her attending physician elected
to do nothing in the way of treatment of atherothrombotic
disease risk factors, particularly dyslipidemia. Some two
years later the patient entered the author’s practice. He
began the patient on statin therapy, combined with aspirin.
Her initial course was marked by hospitalizations for
recurrent chest pains, but after a few years with the addition
of calcium channel blocker therapy for recurrent angina, the
chest pain resolved and has not recurred. The patient is now
101 ½ years old and remains free living in her own home.
There have been no other interventions, medical or surgical.
Conclusions:
This is a report about the success of optimal
medical therapy, including statin therapy with super-statins,
in a 101 ½ year old survivor of an acute myocardial infarction.
This report shows that such therapy can be effective in
control of atherothrombotic disease even in the oldest of
the old.
Speaker Biography
William E. Feeman Jr., MD, is a Physician on staff at Wood County Hospital, and in
private practice, both in Bowling Green, Ohio. He attended undergraduate school
at Ohio State University (1961-1966) and became interested in a career in medicine
during that time; prior to his decision to enter medicine he planned to have a career
in astronomy. He attended undergraduate medical school at Ohio State University,
earning Bachelor of Science in physiology (1961-1966) and medical school at Ohio
State University (1966-1970); where he developed an interest in the primary and
secondary prevention of atherothrombotic disease. Over the last 26 plus years, he has
spent his professional life in medicine perfecting a tool to predict the population at risk
of atherothrombotic disease e and to guide therapy to maximally stabilize/reverse that
disease if extant. Thus he has founded the Bowling Green Study of the Primary and
Secondary Prevention of Atherothrombotic Disease (BGS) to which he is the principal
investigator. This study terminated on 4 November 2003. Dr. Feeman has had six major
articles published in various science/medical journal. He has had numerous letters to
the editor published in various medical journals. All publications relate to the primary
and second prevention of atherothromboitc disease. He has presented data at a
number of annual scientific assemblies of the American Academy of Family Physicians
and at a number of national and international symposia in atherothrombotic disease.
Dr. Feeman is the founder of the Association for the Prevention of Atherothrombotic
Disease in Northwest Ohio to facilitate the spread of knowledge about this disease.
e:
bgs43402@yahoo.comSurvival of a 101 year old survivor of myocardial infarction
William E. Feeman
Bowling Green Study, USA